Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
N-(4-[(2E)-3-(4-ethoxyphenyl)-1-(phenyl)prop-2-en-1-one]) acetamide Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020 1 0
N-(3-(Furan-2-yl)-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl)-3-methylbenzamide Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020 1 0
N-[(3-Fluorophenyl)methyl]-1-[(1r)-1-Naphthalen-1-Ylethyl]piperidine-4-Carboxamide Potential treatment - theoretical effect Experimental Antiviral Aug/04/2020 1 0
N-3-{[(7S)-7-(acetylamino)-1,2,3-trimethoxy-11-(4-methoxyphenyl)-9-oxo-5,6,7,9-tetrahydrobenzo[9,10]heptaleno[3,2-b]furan-12-yl]acetyl}-N-[(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]-beta-alaninamide Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021 1 0
N-[3-[4-[4-(Hydroxymethyl)phenyl]-6-[[2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]methyl]-1,3-dioxan-2-yl]phenyl]acetamide Potential treatment - theoretical effect Experimental Antiviral Oct/20/2020 1 0
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020 1 0
N-[(2S)-1-[[(1S,2S)-1-(1,3-Benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide Potential treatment - pre-clinical evidence Experimental Antiviral Jan/28/2021 1 0
N-[(2R)-2-(1H-Indol-3-yl)-2-thiophen-2-ylethyl]-2-oxo-1H-quinoline-4-carboxamide Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020 1 0
N-[(1R)-2-(Tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2021 1 0
N-[(1R)-2-[4-(1-Methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide Approved for COVID-19 treatment (China, India, Russia) Experimental Antiviral Sep/18/2020 1 0
N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020 1 0
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
MZ1 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
Myricitrin Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020 1 0
Myricetin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021 5 0
Mycophenolic acid Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/05/2020 3 0
MXB-9 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
MXB-4 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021 1 0
MW05/LALA Potential treatment - pre-clinical evidence Experimental Antiviral Nov/13/2020 1 0
MVC-COV1901 Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020 2 0
MVA/S Potential treatment - pre-clinical evidence Experimental Vaccine Feb/03/2021 1 0
MT326715 Potential treatment - theoretical effect Experimental Vaccine Jun/17/2020 1 0
MT326102 Potential treatment - theoretical effect Experimental Vaccine Jun/17/2020 1 0
mRNA-RBD Potential treatment - pre-clinical evidence Experimental Antiviral Feb/03/2021 1 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 25 0
mRBD Potential treatment - pre-clinical evidence Experimental Vaccine Nov/23/2020 1 0
MR3 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/10/2020 1 0
MPI8 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/07/2020 1 0
MPI5 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/07/2020 1 0
Moxifloxacin Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/05/2020 2 0
Moxidectin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 1 0
Motesanib Potential treatment - theoretical effect Experimental Other treatment May/17/2020 1 0
Morin Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021 1 0
Montelukast Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/23/2021 5 0
Monensin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020 2 0
Momelotinib Potential treatment - theoretical effect Experimental Other treatment May/17/2020 1 0
MolPort-000-735-951 Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Molnupiravir Emergency use authorization Experimental Antiviral Jan/20/2022 14 1
mNb6-tri Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020 1 0
mmu-miR-200c Potential treatment - theoretical effect Natural product Other treatment Sep/03/2020 1 0
MLN-4760 Potential treatment - theoretical effect Experimental Antiviral Mar/03/2021 1 0
MLN-3897 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
MK-2206 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 2 0
Mitoxantrone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020 2 0
MIR2911 Potential treatment - clinical evidence Natural product Antiviral Aug/05/2020 1 0
Miglustat Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/18/2020 1 0
Migalastat Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020 1 0
Midostaurin Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020 1 0
Micafungin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 1 0
MI-432 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/15/2020 1 0
MI-30 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021 1 0
MI-1900 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/15/2020 1 0
MI-1851 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/15/2020 1 0
MI-09 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021 1 0
Mezerein Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Metronidazole  Potential treatment - theoretical effect Used to treat other disease Other treatment Mar/30/2020 1 0
Metocurine Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Metoclopramide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/27/2020 1 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 40 4
Methylene blue Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/13/2021 2 0
Methyl allyl disulfide Potential treatment - theoretical effect Natural product Antiviral Mar/31/2020 1 0
Methotrexate  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/14/2020 3 0
Metformin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/14/2021 2 1
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Dec/24/2021 48 0
Merimepodib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/09/2020 1 0
Merimepodib Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
Mercaptopurine Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/16/2020 1 0
Mentha haplocalyx extract Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021 1 0
Menstrual blood-derived stem cells Potential treatment - clinical evidence Experimental Other treatment Mar/06/2021 1 0
Menadione Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021 2 0
Memantine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/20/2020 1 0
Melatonin Potential treatment - theoretical effect Natural product Antiviral Nov/06/2020 4 0
Mefuparib hydrochloride Potential treatment - pre-clinical evidence Experimental Antiviral Mar/26/2021 1 0
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
Mebendazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/16/2020 1 0
MDR504 hACE2-Fc Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2020 1 0
MDL-28170 Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/24/2020 1 0
MB_266 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 1 0
MB_250 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 1 0
MB_241 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 1 0
Maxacalcitol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/23/2020 1 0
MAW-22 Potential treatment - theoretical effect Experimental Antiviral Oct/30/2020 1 0
Masoprocol Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 1 0
Maribavir Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/22/2020 1 0
Maprotiline Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021 1 0
Manidipine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021 3 0
Mahuang Liu Jun Tang Potential treatment - clinical evidence Natural product Unknown Sep/14/2020 1 0
Magnesium Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/10/2020 1 0
Maduramicin Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 2 0
mAb8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021 1 0
MAb362 Potential treatment - pre-clinical evidence Experimental Antiviral Aug/21/2020 1 0
mAb2 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021 1 0
mAb Beta-56 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-55 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-54 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-53 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-47 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-40 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-29 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0